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How Best to Identify
Prognostically Important Left
Ventricular Hypertrophy: A Cut
to the Chase*
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New York, New York
Determinants of left ventricular mass. After birth, myo-
cardial growth largely occurs due to an increase in myocyte size
(hypertrophy) rather than myocyte number (hyperplasia) (1).
During childhood and adolescence, left ventricular mass en-
larges in tandem with increasing body size (2,3). Among the
various measures of body size, left ventricular mass tracks most
closely with lean body mass (2). Myocardial mass is similar in
boys and girls but begins to diverge during adolescence, with
the greater increase in left ventricular mass in men due to the
proportionally greater increases in body height and weight (3).
With aging, left ventricular wall thicknesses increase, whereas
cavity size tends to decrease in normotensive adults, resulting
in no change in overall ventricular mass but a progressive
increase in relative wall thickness (concentric remodeling) (4).
The relation between body size and left ventricular mass
becomes less close in adults because of the superimposition of
conditions predisposing to left ventricular hypertrophy, such as
obesity and hypertension. Obesity is associated with an in-
crease in left ventricular mass in both normotensive and
hypertensive populations, independent of blood pressure (5,6).
Left ventricular hypertrophy in obesity is most commonly
eccentric (6,7), emphasizing the importance of volume load in
determining left ventricular mass (8). The extent to which
hypertension induces myocardial growth and results in left
ventricular hypertrophy is quite variable, depending on the
severity of hypertension and the patient population (9).
Among asymptomatic, mildly hypertensive patients, left ven-
tricular mass was found to be 13% greater than in normoten-
sive subjects similar in age, gender and body size, whereas
frank left ventricular hypertrophy was present in 12% of
hypertensive patients (10).
“Normalization” of left ventricular mass. Because of its
strong relation to body size, a variety of methods have been
utilized to adjust left ventricular mass for differences in body
size. The goals of such “normalization” include the develop-
ment of accurate reference standards for normality and quan-
tification of the impact of disease states, such as hypertension
and obesity, on left ventricular growth. Traditional methods for
adjustment of left ventricular mass have utilized either height
or body surface area, which is determined by both height and
weight. Controversy regarding the preference between these
simple methods centers on the extent to which the impact of
obesity on left ventricular mass is explained: division of
absolute left ventricular mass by body surface area “forgives”
or underestimates the influence of obesity by proportionally
lowering ventricular mass, whereas division by height accentu-
ates the impact of obesity by proportionally elevating ventric-
ular mass.
An attractive alternate method for normalization of left
ventricular mass involves the use of lean body mass. Adjust-
ment of left ventricular mass by lean body mass, measured
using 24-h urinary creatinine excretion, better diminished
observed differences between adult men and women and
between obese and nonobese subjects than did adjustment by
body surface area, height or weight (7). When measured by
dual-energy X-ray absorptiometry, lean body mass explained
75% of the variance in left ventricular mass in black and white
boys and girls (2). Although newer methods of determining
lean body mass, such as bioimpedance and dual-energy X-ray
absorptiometry, may speed the measurement of lean body
mass, the time, expertise, technology and expense involved
may continue to limit the use of this measure of body size as
the optimal method of adjustment.
More recently, de Simone et al. (11) have utilized the
concept of allometric relations among body parts to identify a
more ideal method of adjustment. In this approach, left
ventricular mass may be related by nonlinear regression anal-
ysis to a regression coefficient or constant (b1) times a given
measure of body size raised to the power or allometric signal
(b2) that gives the best fit:
Left ventricular mass5 b1 3Measure of body sizeb2.
Because left ventricular mass is a volumetric, or three-
dimensional measure, whereas body surface area is two-
dimensional, and height is one-dimensional, one might expect
that the allometric signal for left ventricular mass in relation to
body surface area would be 1.5 and that for height would be 3.
In fact, in a large population of normotensive adults and
children, left ventricular mass most closely related to body
surface area to the 1.5 power and height to the 2.7 power (11).
Variability among normal subjects was best minimized, and the
increase in left ventricular mass attributable to obesity (as
estimated using ideal ventricular mass predicted from ideal
weight based on observed height) was most accurately pre-
dicted, by adjustment by height2.7 (11). A similar approach was
subsequently applied to normal, young adults in the Framing-
ham population, and although a different allometric signal was
derived (height1.97), variability in left ventricular mass was
again considerably diminished (12). Although a subsequent
*Editorials published in Journal of the American College of Cardiology reflect
the views of the authors and do not necessarily represent the views of JACC or
the American College of Cardiology.
From the Department of Medicine and the Cardiovascular Center, The New
York Hospital-Cornell Medical Center, New York, New York.
Address for correspondence: Dr. Mary J. Roman, Division of Cardiology,
Box 222, The New York Hospital-Cornell Medical Center, 525 East 68th Street,
New York, New York 10021. E-mail: mroman@mail.med.cornell.edu.
JACC Vol. 29, No. 3
March 1, 1997:648–50
648
q1997 by the American College of Cardiology 0735-1097/97/$17.00
Published by Elsevier Science Inc. PII S0735-1097(97)00007-7
study by de Simone et al. (13) found the allometric signals to be
lower (and more comparable to the Framingham data) when
children and adults were analyzed separately (height2.3 and
height2.13, respectively), cardiovascular risk tended to be best
predicted by adjustment of left ventricular mass by the allo-
metric signal (height2.7) derived using the entire age spectrum
(partition value of 51 g/m2.7).
Prognostic importance of left ventricular hypertrophy.
The debate concerning the optimal method of adjustment of
left ventricular mass for differences in body size and thence the
development of partition values for normality is of clinical
relevance in view of the well established independent contri-
bution of the presence of echocardiographic left ventricular
hypertrophy to an increase in all-cause mortality and cardio-
vascular morbidity and mortality both in the general popula-
tion and among hypertensive patients (14–16). The increased
risk associated with left ventricular hypertrophy is roughly
twofold greater in the general population (15) and even higher
when analyses are limited to hypertensive patients (16). Fur-
thermore, the presence of left ventricular hypertrophy in the
absence of coronary artery disease appears to confer a greater
risk than in the presence of significant coronary disease or
significant left ventricular dysfunction (17), and it may be of
greater prognostic significance in women than in men (18).
The potential mechanisms whereby left ventricular hyper-
trophy might increase morbidity and mortality include 1)
hemodynamic alterations, such as reduced ventricular compli-
ance and elevated filling pressures; 2) a lowered ischemic
threshold of the hypertrophied myocardium; 3) enhanced
arrhythmogenesis; and 4) an association with an increase in
both coronary and extracardiac vascular disease. The evidence
supporting these postulated mechanisms has been recently
reviewed (9).
Current study. The study by Liao et al. (19) in this issue of
the Journal represents an effort to “cut to the chase.” Acknowl-
edging the debate concerning the optimal method of adjust-
ment of left ventricular mass and cognizant of the importance
of the presence of left ventricular hypertrophy in influencing
outcome, the authors compared the predictive value of left
ventricular mass adjusted by various methods for all-cause and
cardiac mortality. Although one might quibble endlessly about
which method results in the least variability and best accounts
for obesity, the ultimate clinical goals are to stratify risk, target
therapy and improve outcome.
The study is a retrospective analysis of 988 consecutive
patients studied with both coronary angiography and echocar-
diography over a 9.5-year period at Cook County Hospital in
Chicago. Obstructive coronary artery disease was present in
54% of patients, and all results are subdivided according to its
presence or absence. During an average follow-up of 7 years,
202 patients died, 127 of cardiac disease and 75 of other causes.
Not surprisingly, when left ventricular mass was considered
a continuous variable (log-transformed and standardized into a
Z score), the relative risks for all-cause and cardiac mortality
were increased with increasing left ventricular mass, regardless
of the method of adjustment, with no differences among the six
methods considered (height, height2, height2.13, height2.7, body
surface area, body surface area1.5). Seven different partition
values (five gender specific) for adjusted left ventricular mass
derived from analyses of the Framingham (20) and Cornell
(13,14,16) populations were then evaluated: three adjusting by
body surface area, two adjusting by height and two adjusting by
height2.7. Although statistical comparisons are not provided,
the presence of left ventricular hypertrophy appeared to carry
a greater risk in the patients without, as opposed to those with,
coronary artery disease, in keeping with a previous report from
the same group (17). Among patients without coronary artery
disease, all partition values conferred an increased risk of
all-cause and cardiac mortality; in general, partition values
based on indexation by body surface area tended to identify
higher risk associated with hypertrophy than those based on
adjustment for height, although the differences were rarely
significant. Among patients with coronary artery disease, rela-
tive risks were again largely similar, and only adjustment by
height2.7 failed to increase relative risk.
Very few patients had left ventricular hypertrophy detected
only by body surface area adjustment. Patients in whom left
ventricular hypertrophy was detected only by height-based
methods of adjustment did not have an increase in relative risk
of death, most likely due to the overall lower left ventricular
mass in this group compared with the group with hypertrophy
also detected by adjustment by body surface area.
In summary, the study demonstrates that increasing left
ventricular mass, regardless of the method of adjustment, is
associated with increasing risk of death. Differences in the
predictive values of the different methods of adjustment arise
only when specific partitions are evaluated, and these differ-
ences are probably attributable to the generally lower absolute
left ventricular mass among patients with height-based rather
than body surface area-based criteria in this predominantly
obese population. The study would appear to confirm the
results of a previous analysis confined to nonhospitalized
hypertensive patients wherein major differences in risk among
the various methods of adjustment were not readily discernible
(13).
Study limitations. One of the major limitations of the
study concerns the highly select nature of its cohort: inner-city,
hospital-based patients, of whom .80% were black, .80%
hypertensive, .50% obese and ;50% had left ventricular
hypertrophy. Furthermore, by definition, all patients must have
undergone coronary angiography for presumed coronary ar-
tery disease. Cardiac deaths are not further characterized, and
significant valvular heart disease does not appear to be an
exclusion criterion and may account for ventricular hypertro-
phy and some of the cardiac deaths among the noncoronary
artery disease group. Despite the unrepresentative nature of
the cohort, it is reassuring that the relative risks associated with
left ventricular hypertrophy are in the same range as those
previously reported.
The relative risk data are exclusively presented after adjust-
ment for age and gender. Given the lack of a clear, much less
strong, association of age with left ventricular mass and the fact
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that most partition values are gender specific, it is unclear why
such adjustment is necessary, and whether it might have
influenced the results. Unfortunately, the relative risks of
partition values based on absolute left ventricular mass were
not fully explored. Finally, as the authors acknowledge, cardio-
vascular morbidity is not considered an end point. Whether
such analyses would enhance or lessen differences in predicting
risk among the different methods of adjustment is uncertain,
although one might predict that obesity-related morbidity
might lessen the differences.
Future directions. The predictive value of the refreshingly
simple measure of absolute left ventricular mass has not been
adequately examined. Despite its dependence on body size,
there may be threshold levels of ventricular mass that exceed
the ability of the microvasculature to adequately sustain and
thereby increase risk. In addition, not only the size but also the
geometry of the left ventricle may be of importance, as
suggested by the enhanced concentration of disease and risk
among hypertensive patients with the concentric pattern of left
ventricular hypertrophy (16,21). Finally, the development and
ready availability of accurate methods to determine lean body
mass may provide the optimal method of adjustment of left
ventricular mass.
Although analyses similar to those in the current study, as
well as assessment of absolute left ventricular mass and
geometric pattern, should certainly be performed in other
populations, one wonders whether an attempt should be made
to pool data from several of the large population-based studies
that have included echocardiography to 1) more confidently
define the limits of normality over a broad range of age, race
and socioeconomic status; 2) further explore the utility of
allometric relations in reducing the variability of left ventricu-
lar mass attributable to body size; and 3) consider development
of partition values based on outcome rather than “normality”
using longitudinal data. Until such time, the presence of left
ventricular hypertrophy, however defined, should alert the
clinician and should stimulate efforts at regression, at least in
the setting of hypertension, in view of preliminary data sug-
gesting benefit and pending the outcomes of large, ongoing
trials designed to evaluate this potential.
I thank Richard B. Devereux, MD for thoughtful review of this editorial.
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